author-photo

T. Graefe

14

Papers

125

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Phase Ib safety and pharmacokinetic evaluation of daily and twice daily oral enzastaurin in combination with pemetrexed in advanced/metastatic cancer

2009 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (20)
Pemetrexed combined with paclitaxel: a dose-finding study evaluating three schedules in solid tumors.

2009 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (7)
Phase-I-study of four different schedules of pemetrexed, gemcitabine and cisplatin in patients with locally advanced or metastatic solid tumours

2008 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (2)
Comparison of enzastaurin pharmacokinetics and safety in the once daily (QD) and twice daily (BID) dose regimens: A phase I study

2007 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Pharmacokinetic interaction and safety of enzastaurin and pemetrexed in patients with advanced or metastatic cancer

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (9)
64 POSTER Phase I study of pemetrexed followed by daily enzastaurin in patients with advanced or metastatic cancer

2006 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (0)
Phase II study of MTX-HSA in combination with Cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma

2006 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (57)
Pemetrexed/gemcitabine/cisplatin: Phase I trial in patients with solid tumors

2004 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Cutaneous metastases of internal cancer

2004
Show All
- Source
- Cite
- Save
Citations (15)
Phase I study of pemetrexed plus paclitaxel in patients with solid tumor

2004 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)